In addition to the CEO and CFO, the SMT consists of Business Unit and functional heads committed to long-term sustainable growth
Simon joined AMS in 2002 as Group Information Systems Manager and, during the Company’s growth since then, he has overseen many key IT projects including implementing ERP systems across the Group, integrating acquisitions and relocating the business into its existing Winsford site. Simon has over 25 years of experience in IT infrastructure, systems implementation and software development gained from a number of different industries. Prior to joining AMS, he was Worldwide IT Manager at Whitford Plastics Ltd, a manufacturer of fluropolymer coatings, supporting them through a period of rapid growth, managing multiple sites and key IT projects including ERP implementation and adoption of the Euro for the European offices. Simon was appointed to the Senior Management Team in January 2015.
Group R&D Director
Andy joined AMS in July 2022 as Group R&D Director. Originally trained as a Pharmacist with a PhD in drug delivery Andy has over 25 years of R&D experience leading teams with responsibilities ranging from Drug Product Development, Device Development and Drug-Device Combination Products. Andy served 17 years at AstraZeneca, where he also gained international experience through roles based in the UK, Sweden and the USA. After leaving AstraZeneca he joined Bespak, spending eight years at their Innovation Centre in Cambridge, UK. Prior to joining AMS, Andy was Vice President Innovation at Bespak (part of the Recipharm Group).
Vice President - Corporate Business Development
Brian joined AMS in July 2009 as GM of the US to initiate a surgical business and launch LiquiBand. Brian graduated with honours and a degree in Marketing/Communications and Entrepreneurial studies from Babson College in 1997 and earned an Executive MBA from the Sawyer School of Management, Suffolk University in 2005. Brian has over 20 years’ experience in Medical Devices; his first 10 at Tyco/Covidien mostly involved with Dental and AWC products. Since joining AMS Brian has been the GM of the US business in which he developed the US team and grew to +20% Market Share; he has also served as Global Director of Marketing for the Surgical BU prior to taking his current post in early 2022.
Group Quality Assurance/ Regulatory Affairs (QA/RA) Director
Rose joined AMS in May 2013 as Group QA/RA Director having completed her Masters Degree in Precision Engineering from Nanyang Technology University in Singapore. Rose has over 20 years experience working for medical device companies and has a strong background in setting up effective quality systems. Rose has worked for Bausch & Lomb International Healthcare, Nypro and spent nine years at Medical House Products plc as Director of Quality, Regulatory Affairs and Operations. Prior to joining AMS, Rose was Head of Quality and Regulatory Affairs at Bespak, part of Consort Medical plc. Rose is also a 6 Sigma Master Black Belt.
Business Unit Director, Surgical
Prior to joining AMS in January 2006 Ross graduated with his BSc from University of Glasgow and then completed an MSc in Entrepreneurial Studies from Glasgow Caledonian University. Following university, Ross then spent five years within the Pharmaceutical industry. Upon joining AMS, from 2006 to 2012, Ross worked across our direct and distributed sales functions both in the UK Sales organisation, before taking on responsibility for the European Woundcare Business in 2010. In 2012 Ross relocated to the US. In his role as National Sales Manager Americas, he contributed to a period of sustained and high growth for the LiquiBand® franchise. In October 2016 Ross returned to the UK to take up a new role as Director of Sales for US, UK and Germany and quickly moved into the Global Sales Director role for the Surgical Business Unit. In January 2021, Ross was appointed to the Business Unit Director role for the Surgical Business Unit.
Group Operations Director
Group HR Director
Cathy joined AMS in May 2017 as Group HR Director. Cathy graduated with a degree in Business Studies from Liverpool John Moores University and completed a Masters in Business Administration at Strathclyde University. She spent five years working for Amazon and was Head of HR for their final mile delivery business (a start-up business for Amazon). Prior to this Cathy held senior HR roles for Xerox (supporting the outsourcing of managed services from government and blue chip organisations to Xerox) and Emirates Airline, based in Dubai (where she supported the growth of the airline in new geographies and acquisitions).
Business Unit Director, Woundcare
Becky joined AMS in July 2015 as Business Unit Director of OEM and Bulk Materials. Becky graduated with a degree in Modern Languages (French and German) with International Studies from South Bank University in 1993 and completed an Executive Masters of Business Administration at Lancaster University in 2000. Becky has more than 13 years’ experience in the Medical Device sector, having held various Senior Management roles, most recently as European Sales Director for Scapa Healthcare.
Owen joined AMS in April 2012 as Assistant Company Secretary and became Deputy Company Secretary in October 2013. Having completed a BA (Hons) in International Business and a Masters in Business Administration (MBA), he helped to launch a licensed Corporate Service Provider on the Isle of Man in 2006 and qualified through the Institute of Chartered Secretaries and Administrators (ICSA) in 2007, now the Chartered Governance Institute. He moved to the UK in 2010, working at Eversheds LLC and GB Group plc prior to AMS. In January 2021, Owen was appointed as Company Secretary.
Group Quality Director
Lynaye joined AMS in February 2023 as Group Quality Director, she has over 13 years’ experience working within the medical device industry, having held various senior roles, most recently as Worldwide Quality Director at Peli BioThermal. Lynaye has a strong background in implementation of effective quality systems with specific focus in compliance, harmonisation across multiple sites, alignment of quality initiatives to strategic business goals, driving operational improvement, cost reduction, and developing a consistent quality culture.